Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $434,400.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $14.48, for a total transaction of $434,400.00. Following the transaction, the president now owns 2,072,899 shares in the company, valued at approximately $30,015,577.52. This trade represents a 1.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, May 14th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.87, for a total value of $446,100.00.
• On Monday, April 14th, Dawn Christine Maroney sold 230,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.10, for a total transaction of $4,393,000.00.
• On Thursday, March 27th, Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.89, for a total transaction of $199,509.28.
• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total value of $271,174.00.

Alignment Healthcare Trading Up 0.5%

Shares of ALHC stock traded up $0.07 during mid-day trading on Tuesday, hitting $14.57. The company had a trading volume of 2,485,444 shares, compared to its average volume of 2,057,970. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69. The stock's 50 day moving average price is $16.28 and its 200-day moving average price is $14.94. Alignment Healthcare, Inc. has a 52-week low of $7.05 and a 52-week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The business had revenue of $926.93 million for the quarter, compared to analysts' expectations of $889.83 million. During the same quarter in the previous year, the company earned ($0.25) EPS. The business's quarterly revenue was up 47.5% compared to the same quarter last year. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Hedge Funds Weigh In On Alignment Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALHC. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after acquiring an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its position in Alignment Healthcare by 54.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock worth $97,302,000 after purchasing an additional 3,059,596 shares during the last quarter. Millennium Management LLC increased its position in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock worth $38,122,000 after purchasing an additional 2,896,311 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Alignment Healthcare during the fourth quarter valued at $20,087,000. Finally, Invesco Ltd. lifted its position in Alignment Healthcare by 1,415.7% during the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company's stock valued at $34,927,000 after purchasing an additional 1,752,033 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Bank of America increased their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a report on Tuesday, March 4th. Stifel Nicolaus lifted their price target on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. Robert W. Baird upped their price target on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Finally, Piper Sandler raised their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $17.17.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.